Structure-based discovery of a boronic acid bioisostere of combretastatin A-4.
Yali Kong, Jolanta Grembecka, Michael C Edler, Ernest Hamel, Susan L Mooberry, Michal Sabat, Jayson Rieger, Milton L Brown
文献索引:Chem. Biol. 12(9) , 1007-14, (2005)
全文:HTML全文
摘要
Targeting the microtubule system represents an attractive strategy for the development of anticancer agents. In this study, we report a class of combretastatin A-4 (CA-4) analogs derivatized with a boronic acid moiety replacing the hydroxyl group on the C-ring of CA-4. Docking studies of the X-ray structures of our aryl-boronic analogs onto an X-ray structure of the alpha,beta-tubulin heterodimer suggested that cis-6 was a potent inhibitor of the colchicine binding. The model indicated that there would be strong hydrogen bonding between the boronic acid moiety and Thr-179 and Val-181 of alpha-tubulin. We demonstrate that the cis-6 boronic acid bioisostere of CA-4: (1) inhibits tubulin assembly, (2) competitively displaces colchicine, and (3) is a low-nanomolar inhibitor of human cancer cell lines. We present this isostere as a class of potent analogs of CA-4.
相关化合物
相关文献:
2006-01-12
[J. Med. Chem. 49(1) , 179-85, (2006)]
22287813
[10th Internatl. Conf. on Organic Synthesis, Bangalore, India, December 1994]
Aromatic bromination of aldehydes and ketones using 1, 3-di-n-butylimidazolium tribromide [BBIm] Br3 ionic liquids under solvent-free conditions. Borikar SP and Daniel T.
[J. Iranian Chem. Soc. 8(2) , 531-36, (2011)]
(2E)-3-(3-Bromo-4-methoxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one. Dutkiewicz g, et al.
[Acta Crystallogr. Sect. E Struct. Rep. Online 67(4) , 1024, (2011)]